|
|
Volumn 4, Issue 2, 2005, Pages 103-
|
|
Tackling tuberculosis
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
1 (6 BROMO 2 METHOXY 3 QUINOLINYL) 4 DIMETHYLAMINO 2 (1 NAPHTHYL) 1 PHENYL 2 BUTANOL;
ISONIAZID;
PROTON TRANSPORTING ADENOSINE TRIPHOSPHATASE;
QUINOLINE DERIVED ANTIINFECTIVE AGENT;
RIFAMPICIN;
TUBERCULOSTATIC AGENT;
UNCLASSIFIED DRUG;
ANTIBACTERIAL ACTIVITY;
DRUG ABSORPTION;
DRUG MECHANISM;
DRUG RESEARCH;
DRUG SAFETY;
DRUG SENSITIVITY;
DRUG TARGETING;
DRUG TOLERABILITY;
DRUG WITHDRAWAL;
EPIDEMIC;
FATALITY;
GEOGRAPHIC DISTRIBUTION;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
INCIDENCE;
INFECTION CONTROL;
MORTALITY;
MYCOBACTERIUM TUBERCULOSIS;
NONHUMAN;
NOTE;
PATIENT COMPLIANCE;
PRIORITY JOURNAL;
PROTEIN TARGETING;
TUBERCULOSIS;
WORLD HEALTH ORGANIZATION;
|
|
EID: 14044275767
PISSN: 14741776
EISSN: None
Source Type: Journal
DOI: 10.1038/nrd1645 Document Type: Note |
|
Times cited : (5)
|
|
References (1)
|
